Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 04, 2025 09:00 ET | Source: Marius Pharmaceuticals LLC

Marius Pharmaceuticals Leads Effort to Redefine Women’s Health Through Testosterone Research

RALEIGH, N.C., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, Inc., today announced the formation of an all-female advisory board to advance the company’s efforts in addressing the...
September 10, 2025 11:30 ET | Source: Marius Pharmaceuticals LLC

Marius Pharmaceuticals and Hims & Hers™ Collaborate to Expand Access to KYZATREX® (testosterone undecanoate) CIII Capsules, the First FDA-Approved Oral Testosterone Therapy Offered on the Hims & Hers Platform

RALEIGH, N.C., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, Inc. today announced a collaboration with Hims & Hers™, one of the largest digital health platforms for men, to make...
May 28, 2025 09:00 ET | Source: Marius Pharmaceuticals LLC

Marius Pharmaceuticals Receives Sixth U.S. Patent Allowance for KYZATREX® (testosterone undecanoate) CIII Capsules Extending Coverage to 2040

RALEIGH, N.C., May 28, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a pharmaceutical company focused on developing innovative therapies for testosterone deficiency, announced today that the...
April 22, 2025 09:00 ET | Source: Marius Pharmaceuticals LLC

Marius Pharmaceuticals Welcomes John "Shrek" Mcphee as Kyzatrex® (testosterone undecanoate) CIII Capsules Patient Ambassador

RALEIGH, N.C., April 22, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a pharmaceutical company focused on developing innovative therapies for testosterone deficiency, announces its partnership...
March 25, 2025 09:00 ET | Source: Marius Pharmaceuticals LLC

Marius Pharmaceuticals Strengthens IP Portfolio with New KYZATREX® (testosterone undecanoate) CIII Capsules Formulation Patent

RALEIGH, N.C., March 25, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a pharmaceutical company focused on developing innovative therapies for testosterone deficiency, announced today that the...
March 03, 2025 15:00 ET | Source: Marius Pharmaceuticals LLC

Marius Pharmaceuticals Partners with Major Academic Medical Center on Education and Research Efforts for Oral Testosterone

RALEIGH, N.C., March 03, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a pharmaceutical company dedicated to developing innovative therapies for testosterone deficiency, has partnered with Duke...
March 03, 2025 08:30 ET | Source: Marius Pharmaceuticals LLC

Marius Pharmaceuticals Helps Drive FDA’s Landmark Testosterone Label Update, Removing Black Box Warning

RALEIGH, N.C., March 03, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, is pleased to announce that the U.S. Food and Drug Administration (FDA) has implemented significant labeling changes for...
February 21, 2025 09:30 ET | Source: Marius Pharmaceuticals LLC

Marius Pharmaceuticals Unveils New Corporate Website and Announces Longevity & Endocrinology Advisory Boards

RALEIGH, N.C., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a biopharmaceutical company dedicated to redefining the treatment of testosterone deficiency, is excited to announce the...
February 11, 2025 14:30 ET | Source: Marius Pharmaceuticals LLC

Marius Pharmaceuticals Announces KYZATREX® (testosterone undecanoate) CIII Capsules Availability Through Thrive, Expanding Men's Health Solutions

RALEIGH, N.C., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals is pleased to announce that Thrive, a leading provider of personalized healthcare solutions and a trusted partner of O2...
January 14, 2025 09:00 ET | Source: Marius Pharmaceuticals LLC

Marius Pharmaceuticals Partners with US Specialists Management, LLC (“USSM”) Through Affiliated Urologic In-office Dispensaries

RALEIGH, N.C., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, a pharmaceutical company focused on developing innovative therapies for testosterone deficiency, has partnered with USSM, an...